Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for Interleukin 13 receptor alpha 2
Most Correlated Studies
- L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
- L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
- L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
- L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
- L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
Most Relevant Literature
- Silencing of IL13RA2 promotes partial epithelial-mesenchymal transition in hepatocellular carcinoma …
- Mucosal IL13RA2 expression predicts nonresponse to anti-TNF therapy in Crohn's disease.
- Interleukin 13 receptor alpha 2 (IL13Rα2): Expression, signaling pathways and therapeutic applicatio…
- Construction of a prognostic value model in papillary renal cell carcinoma by immune-related genes.
- IL13Rα2‑ and EGFR‑targeted pseudomonas exotoxin potentiates the TRAIL‑mediated death of GBM cells.
Most Relevant Clinical Trials
- BLOC-ICH: Interleukin-1 Receptor Antagonist in Intracerebral Haemorrhage
- Single Ascending Doses Study of Anti- Interleukin-7 Receptor α Monoclonal Antibody (GSK2618960) in H…
- Inflammation in Chronic Kidney Disease and Cardiovascular Disease - The Role of Genetics and Interle…
- IL13 Signaling in Allergic Asthma
- Recombinant Interleukin-7 (CYT107) to Treat Patients With Refractory Nontuberculous Mycobacterial Lu…
